Kezar Life Sciences, Inc. (KZR) Operating Lease, Right-of-Use Asset USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Kezar Life Sciences, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from 2018 to 2024.
  • Kezar Life Sciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $4.36 M, a 52.6% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $4.36 M -$4.84 M -52.6% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $4.78 M -$4.96 M -51% Dec 31, 2023 10-Q 2024-05-09
Q3 2023 $8.07 M +$5.88 M +268% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $8.65 M +$6.27 M +264% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $9.2 M +$6.66 M +261% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $9.74 M +$7.03 M +259% Dec 31, 2022 10-K 2024-03-14
Q3 2022 $2.19 M -$682 K -23.7% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $2.37 M -$653 K -21.6% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $2.55 M -$626 K -19.7% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $2.71 M -$600 K -18.1% Dec 31, 2021 10-K 2023-03-14
Q3 2021 $2.87 M -$574 K -16.6% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $3.03 M -$549 K -15.4% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $3.17 M -$526 K -14.2% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 $3.31 M -$503 K -13.2% Dec 31, 2020 10-K 2022-03-17
Q3 2020 $3.45 M -$481 K -12.2% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $3.58 M -$460 K -11.4% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $3.7 M -$440 K -10.6% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $3.82 M -$383 K -9.12% Dec 31, 2019 10-K 2021-03-11
Q3 2019 $3.93 M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $4.04 M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $4.14 M Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $4.2 M Dec 31, 2018 10-K 2019-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.